Interestingly, a previous study with 468 unselected patients with papillary thyroid cancer found that carriers of truncating CHEK2 mutations had a six-fold increase in risk for a papillary thyroid carcinoma [29]. Here, CHEK2 is linked to differentiated thyroid carcinoma.